Andreas Halvorsen acquired 69.4 Million Roivant Sciences Ltd shares worth $780 Million. That's 2.75% of their equity portfolio (14th largest holding). The investor owns 8.50% of the outstanding Roivant Sciences Ltd stock. The first Roivant Sciences Ltd trade was made in Q4 2021. Since then Andreas Halvorsen bought shares two more times and sold shares on three occasions. The stake costed the investor $602 Million, netting the investor a gain of 30% so far.